Healthrageous Secures $6.5 Million Series B Funding

Healthrageous Secures $6.5 Million Series B Funding

<0> Lois Paul and PartnersSusan McCarron, 617-986-5767 </0>

, a leader in digital health self-management , has received $6.5 million in Series B financing from North Bridge Venture Partners, Egan-Managed Capital, Long River and an undisclosed investor. This latest round, which brings the company’s total financing to $15 million since 2010, will be used to further enhance its consumer facing user interfaces (web and mobile app), analytics engines, and machine learning platform.

By enhancing its capabilities, Healthrageous will enable deeper personalization – from individual level program design to incentives. Consumers will be able to define their reason for maintaining or improving their health, creating their own plan and approach (based on evidence-based guidelines) and, with intuitive ease, assembling the tools and selecting the rewards that are the most appealing and meaningful to support lifestyle behavioral changes. Deeper personalization means superior engagement, improved health outcomes, reduced utilization for health plans and lower hospital readmission rates. For pharmaceutical companies, this approach fosters medication adherence, it helps consumers understand when they need to speak with their physician regarding a medication change, and it creates greater brand loyalty.

“With the industry’s shift to new models of care, health plans and pharmas are incented to keep consumers engaged in adopting and maintaining the lifestyle behaviors that impact individual health status. Healthrageous’ data has revealed that the current approach of offering a one-size-fits-all program doesn’t adequately address individual goals for maintaining or improving health,” . “We offer the only solution that not only tracks and analyzes key biometric measures of health status over time, but also engages consumers in meaningful and personalized ways to ensure longevity and mitigate limitations from lifestyle-induced illness. We are extremely proud of the impact we are making in helping people to realize their dreams.”

Data from more than 10,000 individual users shows that about 30 percent of those utilizing the Healthrageous platform to either improve a lifestyle behavior or manage a chronic condition achieve a clinically significant improvement in their health, indicated by reduced medical utilization as well as lower risk for serious illness.

“Healthrageous is reinventing lifestyle medicine. – from wanting to play with grandchildren to walking a daughter down the aisle – and with each decision a user makes, the Healthrageous application becomes smarter about his or her individual preferences and health challenges,” said Bill Geary, investor at North Bridge Venture Partners. “Healthrageous has only begun to scratch the surface of empowering consumers, which will ultimately improve the health of our population and the bottom lines of health plans, employers and pharmas.”

Healthrageous, Inc. is a personalized health technology company that supports individual journeys to prevent and self-manage chronic health conditions via the web and a mobile app. It achieves superior engagement through its proprietary platform that incorporates personalized goal setting, health journey maps with gaming dynamics, timely biometric feedback and interactive digital coaching. The digital coach leverages multiple tools such as inspirational messages, recognition and incentives, challenges, social networking, trackers and reminders, and interactive educational content.

The company’s solutions are based on technologies developed at the Center for Connected Health, a division of Partners HealthCare, founded by Brigham and Women’s Hospital and Massachusetts General Hospital, teaching affiliates of Harvard Medical School. Connect: , and .


The Real Payback of Healthcare Analytics

With the unpredictability of healthcare today, organizations are sharpening their focus on analytics to make more data-informed decisions. Join us for a roundtable session in which thought leaders will discuss how they are maximizing their analytics investments.